Kim LeBlanc

1.2k total citations
22 papers, 735 citations indexed

About

Kim LeBlanc is a scholar working on Surgery, Molecular Biology and Pharmacology. According to data from OpenAlex, Kim LeBlanc has authored 22 papers receiving a total of 735 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Surgery, 4 papers in Molecular Biology and 4 papers in Pharmacology. Recurrent topics in Kim LeBlanc's work include Pressure Ulcer Prevention and Management (3 papers), Wound Healing and Treatments (3 papers) and Estrogen and related hormone effects (3 papers). Kim LeBlanc is often cited by papers focused on Pressure Ulcer Prevention and Management (3 papers), Wound Healing and Treatments (3 papers) and Estrogen and related hormone effects (3 papers). Kim LeBlanc collaborates with scholars based in United States, Canada and United Kingdom. Kim LeBlanc's co-authors include Karl A. LeBlanc, Éric Asselin, Herbert L. Muncie, Tony Waters, Sophie Parent, Isabelle Mathieu, Véronique Gagnon, Céline Van Themsche, Kevin Woo and Sharon Baranoski and has published in prestigious journals such as Cancer Research, Molecular Cancer and Annals of Emergency Medicine.

In The Last Decade

Kim LeBlanc

21 papers receiving 697 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kim LeBlanc United States 15 271 180 101 75 73 22 735
Julia Rey Germany 12 96 0.4× 42 0.2× 62 0.6× 362 4.8× 28 0.4× 37 865
Iêda Maria Magalhães Laurindo Brazil 22 93 0.3× 79 0.4× 57 0.6× 46 0.6× 84 1.2× 62 1.1k
Marcus Köller Austria 16 92 0.3× 97 0.5× 40 0.4× 107 1.4× 65 0.9× 38 857
Giuseppe Lassandro Italy 17 87 0.3× 70 0.4× 31 0.3× 20 0.3× 42 0.6× 51 697
Xinyuan Li China 15 97 0.4× 446 2.5× 16 0.2× 133 1.8× 20 0.3× 26 842
Hui‐Chen Lee Taiwan 9 100 0.4× 128 0.7× 35 0.3× 59 0.8× 17 0.2× 12 391
Andrzej Nowakowski Poland 16 153 0.6× 163 0.9× 18 0.2× 100 1.3× 119 1.6× 102 721
Chris Fraser Australia 16 71 0.3× 201 1.1× 7 0.1× 193 2.6× 48 0.7× 42 1.0k

Countries citing papers authored by Kim LeBlanc

Since Specialization
Citations

This map shows the geographic impact of Kim LeBlanc's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kim LeBlanc with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kim LeBlanc more than expected).

Fields of papers citing papers by Kim LeBlanc

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kim LeBlanc. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kim LeBlanc. The network helps show where Kim LeBlanc may publish in the future.

Co-authorship network of co-authors of Kim LeBlanc

This figure shows the co-authorship network connecting the top 25 collaborators of Kim LeBlanc. A scholar is included among the top collaborators of Kim LeBlanc based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kim LeBlanc. Kim LeBlanc is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
LeBlanc, Kim, et al.. (2019). Skin tears: prevention and management. British Journal of Community Nursing. 24(Sup9). S12–S18. 14 indexed citations
2.
Woo, Kevin & Kim LeBlanc. (2018). Prevalence of skin tears among frail older adults living in Canadian long-term care facilities. International Journal of Palliative Nursing. 24(6). 288–294. 27 indexed citations
3.
Alexander, Tobias, Attilio Bondanza, Paolo A. Muraro, et al.. (2014). SCT for severe autoimmune diseases: consensus guidelines of the European Society for Blood and Marrow Transplantation for immune monitoring and biobanking. Bone Marrow Transplantation. 50(2). 173–180. 62 indexed citations
4.
LeBlanc, Kim, et al.. (2014). Hip fracture: diagnosis, treatment, and secondary prevention.. PubMed. 89(12). 945–51. 113 indexed citations
5.
LeBlanc, Kim, et al.. (2010). Musculoskeletal Disorders. Primary Care Clinics in Office Practice. 37(2). 389–406. 16 indexed citations
6.
LeBlanc, Kim & Sharon Baranoski. (2009). Prevention and Management of Skin Tears. Advances in Skin & Wound Care. 22(7). 325–332. 25 indexed citations
7.
LeBlanc, Kim. (2008). Fostering rural physicians: the early success of the rural scholars track at Louisiana State University Health Sciences Center School of Medicine--New Orleans.. PubMed. 160(3). 142, 144–6, 148. 2 indexed citations
8.
LeBlanc, Kim, et al.. (2007). Effects of 4-hydroxytamoxifen, raloxifene and ICI 182 780 on survival of uterine cancer cell lines in the presence and absence of exogenous estrogens.. PubMed. 30(2). 477–87. 36 indexed citations
9.
Diaz, James H. & Kim LeBlanc. (2007). Common spider bites.. PubMed. 75(6). 869–73. 14 indexed citations
10.
Themsche, Céline Van, et al.. (2006). Resveratrol interferes with AKT activity and triggers apoptosis in human uterine cancer cells. Molecular Cancer. 5(1). 45–45. 107 indexed citations
11.
LeBlanc, Kim, et al.. (2005). Resveratrol mediates cell fate in human uterine cancer cells through prostaglandin inhibition. Cancer Research. 65. 177–177. 1 indexed citations
12.
LeBlanc, Kim, et al.. (2005). Uterine cancer cells proliferate differently in response to 17β-estradiol in presence or absence of tamoxifen, raloxifen and ICI 182 780. Cancer Research. 65. 947–947. 1 indexed citations
13.
Gagnon, Véronique, et al.. (2004). AKT involvement in cisplatin chemoresistance of human uterine cancer cells. Gynecologic Oncology. 94(3). 785–795. 96 indexed citations
14.
LeBlanc, Kim. (2004). Ankle problems masquerading as sprains. Primary Care Clinics in Office Practice. 31(4). 1055–1067. 6 indexed citations
15.
LeBlanc, Kim & Karl A. LeBlanc. (2003). Groin pain in athletes. Hernia. 7(2). 68–71. 78 indexed citations
16.
Allen, Jason D., et al.. (2001). Forearm Vasoreactivity in Type I Diabetic Subjects. Canadian Journal of Applied Physiology. 26(1). 34–43. 7 indexed citations
17.
LeBlanc, Kim. (1999). Concussion in sport: Diagnosis, management, return to competition. Comprehensive Therapy. 25(1). 39–44. 15 indexed citations
18.
Herndon, David N., Joseph C. Stothert, Lillian D. Traber, et al.. (1988). Effect of antibody-mediated neutropenia on the cardiopulmonary response to endotoxemia. Journal of Surgical Research. 45(3). 266–275. 8 indexed citations
19.
LeBlanc, Kim. (1982). Jejuno-jejunal intussusception in a hemophiliac: A case report. Annals of Emergency Medicine. 11(3). 149–151. 21 indexed citations
20.
LeBlanc, Kim. (1980). A Second Case of Quinidine-Induced Thrombocytopenia With Pulmonary Hemorrhage. Archives of Internal Medicine. 140(9). 1250–1250.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026